Alex Sum
First SEC filing: March 27, 2024 · Latest: March 27, 2024
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 10, 2026 | GCTS | A | 75,000 | · | · | 258,743 Direct | +40.82% | Acquired | (price as of 2026-10-02) |
| Sept. 19, 2025 | GCTS | A | 75,000 | · | · | 183,743 Direct | +68.97% | Acquired | (price as of 2026-10-02) |
| Feb. 19, 2025 | GCTS | M | 13,259 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 19, 2025 | GCTS | M | 13,259 | $0.11 | $1,458 | 108,743 Direct | +13.89% | Acquired | 1945.5% (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 9,338 | · | · | 9,338 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 13,540 | · | · | 13,540 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 13,820 | · | · | 13,820 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 13,259 | · | · | 13,259 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 5,341 | · | · | 5,341 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 90,143 | · | · | 90,143 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 9,338 | · | · | 9,338 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 13,540 | · | · | 13,540 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 13,820 | · | · | 13,820 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 13,259 | · | · | 13,259 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 5,341 | · | · | 5,341 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2024 | GCTS | A | 90,142 | · | · | 90,142 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 19, 2025 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | Feb. 23, 2025 | 13,259 | Disposed |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | June 8, 2030 | 9,338 | Acquired |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | April 19, 2029 | 13,540 | Acquired |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | March 14, 2028 | 13,820 | Acquired |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | Feb. 23, 2025 | 13,259 | Acquired |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | Jan. 1, 2030 | 9,338 | Acquired |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | Jan. 1, 2029 | 13,540 | Acquired |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | Jan. 1, 2028 | 13,820 | Acquired |
| March 26, 2024 | GCTS | Stock Option (Right to Buy) | Common Stock | $0.11 | Jan. 1, 2025 | 13,259 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $303,100 | · | · | · | · | · | $8,961 | $434,311 |
| 2024 | $303,100 | · | · | · | · | · | $9,043 | $312,143 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.